Article Number of Participants Age (s) Diagnoses Setting Dependent Variable Intervention Implemented Treatment Package or

Article

Number of Participants

Age (s)

Diagnoses

Setting

Dependent Variable

Intervention Implemented

Treatment Package or Independent

Outcome

Albert et al., 2020

Berkley et al., 2020

Carson et al., 2020

Douglas et al., 2020

Measures

Upon meeting inclusion criteria, the articles were then analyzed and quantified across several dimensions: (1) participants, (2) setting, (3) dependent variable, (4) intervention implemented and (5) outcome and generalization.


Participants

Data were collected on the number of participants, age of the participant, and diagnosis. Participants were categorized based on age into four subcategories: 2-3 years old, 4-5 years old, 6-7 years old, 8-9 years old, and 10-12 years old. The participants were also scored based on their stated diagnosis: Autism/Pervasive Developmental Disorder, multiple disabilities, medical disability, sensory impairment, failure to thrive, other disability noted, and/or no disability specified. It was also noted how many participants were included in each of the reviewed studies.

**REPEAT FOR ALL MEASURES- see literature review examples for further examples**

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Neurotransmitter Table Neuro transmitter

Neurotransmitter Table Neuro transmitter Receptor Subtype Location/Function/Effects/symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA NMDA GABA GABA a GABA b Serotonin 5HT 5HT 1a 5HT 1B 5HT 1d

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl (2021), this drug is a norepinephrine reuptake inhibitor and a selective norepinephrine inhibitor. Atomoxetine boosts norepinephrine/noradrenaline and increased dopamine in the prefrontal cortex. It also

2/19/24, 7:02 PM SLP – HRM401 Staffing Organizations (2024JAN08FT-1) 1/5 Module 4 – SLP EMPLOYEE RETENTION For this SLP assignment, review the

2/19/24, 7:02 PM SLP – HRM401 Staffing Organizations (2024JAN08FT-1) 1/5 Module 4 – SLP EMPLOYEE RETENTION For this SLP assignment, review the following: Arthur, D. (2019). Chapter 17: Online employee orientation. In Recruiting, interviewing, selecting, & orienting new employees (6th ed.). Harper Collins [Books 24/7]. Available in the Trident Online

NR 546 Week 7 Case Study- child and adolescent Subjective

NR 546 Week 7 Case Study- child and adolescent Subjective Objective The client is an 7-year-old male accompanied by his mother and 9-year-old brother. Client’s Chief Complaints: “My son is getting in trouble at school due to his behavioral. He has endless energy; he can’t sit still. When he plays,

ADHD Table Drug Name (include if IR, XR, ODT, LA)

ADHD Table Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Dexmethylphenidate (Focalin) (D) Jornay PM Amphetamine (Adzenzys) Dextroamphetamine/amphetamine salts (Adderall, Mydayis )